Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database-Reference-Cited by-同舟云学术

Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database

Published:2020-08-10 Issue:11 Volume:40 Page:1021-1040
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Ziyadeh Najat J.^ORCID,Geldhof Anja,Noël Wim,Otero-Lobato Marijo,Esslinger Suzan,Chakravarty Soumya D.,Wang Yiting,Seeger John D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-020-00959-7.pdf

Reference53 articles.

1. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis. 2002 Update. Arthritis Rheum. 2002;2002(46):328–46.

2. Singh JA, Saag KG, Bridges SL, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2016;68:1–25.

3. World Health Organization. Chronic rheumatic conditions. Geneva: World Health Organization; 2017. http://www.who.int/chp/topics/rheumatic/en/. Accessed 24 Oct 2019.

4. Goldman L, Ausiello D, editors. Cecil medicine, 23rd edn. Philadelphia: Saunders Elsevier; 2007. http://www.mdconsult.com. Accessed 24 Oct 2019.

5. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–38.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of inflammatory biomarkers in the association between rheumatoid arthritis and depression: a Mendelian randomization study;Inflammopharmacology;2023-05-06